SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-174778
Filing Date
2020-06-22
Accepted
2020-06-22 07:55:00
Documents
6
Period of Report
2020-06-19
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d946941d8k.htm 8-K 33794
2 EX-3.1 d946941dex31.htm EX-3.1 5068
3 EX-3.2 d946941dex32.htm EX-3.2 48025
4 EX-99.1 d946941dex991.htm EX-99.1 11197
5 GRAPHIC g946941g13w03.jpg GRAPHIC 2808
6 GRAPHIC g946941g41n77.jpg GRAPHIC 4446
  Complete submission text file 0001193125-20-174778.txt   110052
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23143 | Film No.: 20977179
SIC: 2834 Pharmaceutical Preparations